CONDENSED CONSOLIDATED BALANCE SHEETS (USD $) In Millions, unless otherwise specified	Mar. 31, 2012	Dec. 31, 2011
Current assets:
Cash and cash equivalents	$ 229.5	$ 246.0
Restricted cash	3.6	2.2
Accounts receivable, net	261.8	282.8
Inventories	648.0	576.2
Other current assets	102.5	86.9
Total current assets	1,245.4	1,194.1
Property, plant and equipment, net	261.8	249.0
Intangibles, net and other long-term assets	290.1	267.4
Total assets	1,797.3	1,710.5
Current liabilities:
Current portion of long-term debt	76.3	83.7
Accounts payable	87.0	72.3
Customer advances	300.2	268.6
Other current liabilities	308.0	331.2
Total current liabilities	771.5	755.8
Long-term debt	243.3	219.4
Other long-term liabilities	120.4	110.4
Commitments and contingencies (Note 11)
Shareholders' equity:
Preferred stock, $0.01 par value 5,000,000 shares authorized, none issued or outstanding
Common stock, $0.01 par value 260,000,000 shares authorized, 166,113,161 and 165,892,170 shares issued and 166,092,582 and 165,871,905 shares outstanding at March 31, 2012 and December 31, 2011, respectively	1.7	1.7
Treasury stock, at cost, 20,579 and 20,265 shares at March 31, 2012 and December 31, 2011, respectively	(0.2)	(0.2)
Other shareholders' equity	657.1	620.0
Total shareholders' equity attributable to Bruker Corporation	658.6	621.5
Noncontrolling interest in consolidated subsidiaries	3.5	3.4
Total shareholders' equity	662.1	624.9
Total liabilities and shareholders' equity	$ 1,797.3	$ 1,710.5